Since it was established in 1992, the Germany company has evolved from a manufacturer of veterinary medicines to a successful provider of specialty pharmaceuticals for therapeutic niches in the field of human medicine, and has chalked up more than 400 approvals worldwide.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze